- Novartis Sneaks Ahead in Race to Deliver MS Pills (PharmaTimes)
- GSK Gives Price Pledge on Experimental Malaria Vaccine (Financial Times)
- Merck HIV Drug from Schering Merger Fails Trials (Reuters)
- Pharma Cuts in Early In-House R&D is Clever Move – Analysts (PharmaTimes)
- Alcon Fumes Over ‘Grossly Inadequate’ Novartis Bid (PharmaTimes)
- Tylenol Recall in Effect Includes Several Other Drugs (HealthNews Daily)
- Auxillium To Get $15 Million Payment From Pfizer (PharmaLive)
- Bristol-Myers Squibb Supporting Efforts to Help Survivors (Pharma World News)
- Inspire Pharma Eye Drug Fails in Late-Stage Trial (Reuters)
- Novartis Gets Japan’s Approval for Three Drugs (Reuters)
SUBSCRIBE